These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2457162)

  • 1. Neurochemical basis for cocaine and methamphetamine interactions.
    Hanson G; Matsuda L; Gibb J
    NIDA Res Monogr; 1988; 81():94-100. PubMed ID: 2457162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on monoamine levels in rat CNS after chronic administration of cocaine.
    Alburges ME; Wamsley JK
    Invest Clin; 1993; 34(4):181-92. PubMed ID: 7516188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats.
    Kitanaka N; Kitanaka J; Watabe K; Takemura M
    Neuroscience; 2010 Feb; 165(4):1370-6. PubMed ID: 19958817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
    Sonsalla PK; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical effects of repeated or continuous exposure to cocaine.
    Kleven M; Woolverton W; Schuster C; Seiden L
    NIDA Res Monogr; 1988; 81():86-93. PubMed ID: 2457161
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cocaine on methamphetamine-induced neurochemical changes: characterization of cocaine as a monoamine uptake blocker.
    Hanson GR; Matsuda LA; Gibb JW
    J Pharmacol Exp Ther; 1987 Aug; 242(2):507-13. PubMed ID: 2886643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion.
    Horner KA; Adams DH; Hanson GR; Keefe KA
    Neuroscience; 2005; 131(1):67-77. PubMed ID: 15680692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
    Ritter JK; Schmidt CJ; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1984 May; 229(2):487-92. PubMed ID: 6201607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.
    Wagner GC; Carelli RM; Jarvis MF
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):221-8. PubMed ID: 3992009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rotational behavior induced by methamphetamine and cocaine in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal dopamine system].
    Miyata H; Hironaka N; Ando K; Yanagita T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):111-5. PubMed ID: 8042345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin.
    Gibb JW; Bush L; Hanson GR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):630-5. PubMed ID: 9353379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dopamine in the neurotoxic effects of methamphetamine.
    Schmidt CJ; Ritter JK; Sonsalla PK; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1985 Jun; 233(3):539-44. PubMed ID: 2409267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced spectrin proteolysis in the rat striatum.
    Staszewski RD; Yamamoto BK
    J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.